Improvement of Ankle-Brachial Index by DLBS1033 Treatment in Diabetic Patients With Peripheral Arterial Disease
Phase of Trial: Phase II/III
Latest Information Update: 03 Aug 2018
Price : $35 *
At a glance
- Drugs Lumbricus rubellus (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Sponsors Dexa Medica
- 31 Aug 2018 Biomarkers information updated
- 24 Jul 2018 Status changed from active, no longer recruiting to discontinued.
- 27 Apr 2018 Status changed from recruiting to active, no longer recruiting.